MACC1 mRNA high expression was significantly related to poor PFS in 483 serous carcinomas (HR = 1.45 (95% CI: 1.16 – 1.82), P = 0.0013) and in 494 patients with stage III or IV (HR = 1.50 (95% CI: 1.21 – 1.86), P = 0.00024) (Table 2). Here, MACC1 is linked to serous adenocarcinoma.